Global Cell Separation Technology Market
End-User (Research Laboratories & Institutes, Biotechnology & Biopharmaceutical Companies, Hospitals & Diagnostic Laboratories, Cell Banks)
Research laboratories & institute segment in the cell separation technology market is set to exceed USD 16.5 Billion by the end of 2037, up from USD 2.2 billion in 2024. Cell separation technology is employed in research laboratories and institutes to conduct tests on isolated cells, execute molecular analysis, modify genetically, and expand a specific cell type for cell therapy research, and disease modeling applications.
Moreover, the prevalence of diseases such as diabetes, and arthritis along with the sudden outbreak of other diseases supports the expansion of the research laboratories & institute segment. As per the estimations of the WHO, over 422 million people across the globe have diabetes, most of them residing in low-and middle-income nations, and 1.5 million deaths are influenced by diabetes each year. Consequently, these institutions serve as important centers for innovation and cutting-edge research. Owing to this the cell separation technology market is projected to rise over the years to come.
Product (Instruments, Consumables & Reagents)
The consumables & reagents segment in cell separation technology market is predicted to rise gathering the highest revenue by the end of 2037 compared to the year 2024. Consumables and reagents employed for cell separation are essential for numerous uses in life sciences and biomedical research. Consumables comprise media, separation reagents, enrichment solutions, beads, magnets, columns, cells, and others. Their selectivity facilitates the rapid and efficient sorting of cells. Magnetic beads, for instance, coated with antibodies that are particular to cell surface indicators, might be used to isolate target cells when exposed to a magnetic field.
Application [Biomedical Research (Cancer Research, Immunology, Stem Cell Research, Neurobiology), Therapeutics (Regenerative Medicine, Cell Therapy, Transplantation), Diagnostics, Protein Therapeutics Production, Others]
In cell separation technology market, biomedical segment is anticipated to reach USD 21.6 Billion by 2037. This segment is set to generate revenue of USD 2.9 billion in the year 2024. Amongst this segment, the cancer research sub-segment is projected to observe significant growth in its revenue. This could be encouraged by growing investment in cancer research. For instance, between 2016 to 2020 over USD 23 billion was funded for cancer research across the globe from about 66,387 public and philanthropic awards.
Our in-depth analysis of the cell separation technology market includes the following segments:
Product |
|
Technology |
|
Application |
|
End-User |
|
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?